Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 6/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.45 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27536033 | 0.98 | HTR2A (0.46) | HTR2AHTR2CHTR2BARADORA3 | |
| SCHEMBL237581 | 0.82 | AR (0.47) | HTR2AHTR2CHTR2BARADORA3 | |
| SCHEMBL29967921 | 0.82 | AR (0.47) | HTR2AHTR2CHTR2BARADORA3 | |
| SCHEMBL6184401 | 0.78 | AR (0.41) | HTR2AHTR2CHTR2BARADORA3 | |
| SCHEMBL3080406 | 0.77 | AR (0.44) | HTR2AHTR2CHTR2BARADORA3 | |
| SCHEMBL5136991 | 0.76 | HTR2A (0.44) | HTR2AHTR2CHTR2BARADORA3 | |
| Phenol SCHEMBL1863763 | 0.75 | TSHR (0.45) | HTR2AHTR2CHTR2BARADORA3 | |
| Phenol SCHEMBL1270631 | 0.75 | TSHR (0.45) | HTR2AHTR2CHTR2BARADORA3 | |
| SCHEMBL30317690 | 0.74 | AR (0.45) | HTR2AHTR2CHTR2BARADORA3 | |
| SCHEMBL1389255 | 0.72 | AR (0.41) | HTR2AHTR2CHTR2BARADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000044931-A2 | HIGH-THROUGHPUT SCREENING ASSAYS FOR MODULATORS OF ATPASE | BION, INC. (US) | 2000-08-03 | — | — | WO | claimed |
| US-12281092-B2 | Compound or salt thereof, composition, chemiluminescence method, method for measuring chemiluminescence signal, reagent, reagent kit, and method for assaying analyte | SYSMEX CORPORATION (JP) | 2025-04-22 | — | — | US | disclosed |
| US-20230242499-A1 | COMPOUND OR SALT THEREOF, COMPOSITION, CHEMILUMINESCENCE METHOD, METHOD FOR MEASURING CHEMILUMINESCENCE SIGNAL, REAGENT, REAGENT KIT, AND METHOD FOR ASSAYING ANALYTE | SYSMEX CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| EP-4219651-A1 | COMPOUND OR SALT THEREOF, COMPOSITION, CHEMILUMINESCENCE METHOD, METHOD FOR MEASURING CHEMILUMINESCENCE SIGNAL, REAGENT, REAGENT KIT, AND METHOD FOR ASSAYING ANALYTE | SYSMEX CORPORATION (JP) | 2023-08-02 | — | — | EP | disclosed |
| EP-1038037-A4 | SCREENING ASSAYS FOR THE DETECTION AND DIAGNOSIS OF INFLUENZA VIRUS | SEPRACOR INC (US) | 2003-02-12 | — | — | EP | disclosed |
| CN-1285003-A | Screening method for detecting and diagnosing influenza virus | SEPRACOR INC (US) | 2001-02-21 | — | — | CN | disclosed |
| EP-1038037-A1 | SCREENING ASSAYS FOR THE DETECTION AND DIAGNOSIS OF INFLUENZA VIRUS | SEPRACOR, INC. (US) | 2000-09-27 | — | — | EP | disclosed |
| WO-2000044931-A2 | HIGH-THROUGHPUT SCREENING ASSAYS FOR MODULATORS OF ATPASE | BION, INC. (US) | 2000-08-03 | — | — | WO | disclosed |
| WO-1999031280-A1 | SCREENING ASSAYS FOR THE DETECTION AND DIAGNOSIS OF INFLUENZA VIRUS | SEPRACOR INC. (US) | 1999-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12281092-B2 | Compound or salt thereof, composition, chemiluminescence method, method for measuring chemiluminescence signal, reagent, reagent kit, and method for assaying analyte | JAK2, MPO, PEAK1 | HTR2A 4784/4885HTR2C 4725/4885HTR2B 4474/4885 |
| US-20230242499-A1 | COMPOUND OR SALT THEREOF, COMPOSITION, CHEMILUMINESCENCE METHOD, METHOD FOR MEASURING CHEMILUMINESCENCE SIGNAL, REAGENT, REAGENT KIT, AND METHOD FOR ASSAYING ANALYTE | JAK2, MPO, PEAK1 | HTR2A 4784/4885HTR2C 4725/4885HTR2B 4474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.